Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-24-004460
Filing Date
2024-06-25
Accepted
2024-06-25 16:27:45
Documents
77
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q FOR3/31/24 cpmd_i10q-033124.htm   iXBRL 10-Q 746689
2 CERTIFICATION cpmd_ex3101.htm EX-31.1 11647
3 CERTIFICATION cpmd_ex3102.htm EX-31.2 11691
4 CERTIFICATION cpmd_ex3200.htm EX-32 4766
  Complete submission text file 0001683168-24-004460.txt   4593857

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE cpmd-20240331.xsd EX-101.SCH 49060
6 XBRL CALCULATION FILE cpmd-20240331_cal.xml EX-101.CAL 59929
7 XBRL DEFINITION FILE cpmd-20240331_def.xml EX-101.DEF 161618
8 XBRL LABEL FILE cpmd-20240331_lab.xml EX-101.LAB 328545
9 XBRL PRESENTATION FILE cpmd-20240331_pre.xml EX-101.PRE 289649
81 EXTRACTED XBRL INSTANCE DOCUMENT cpmd_i10q-033124_htm.xml XML 556508
Mailing Address SUITE 3600 888 3RD STREET SW CALGARY A0 T2P 5C5
Business Address SUITE 3600 888 3RD STREET SW CALGARY A0 T2P 5C5 949-652-6838
CANNAPHARMARX, INC. (Filer) CIK: 0001081938 (see all company filings)

EIN.: 274635140 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-27055 | Film No.: 241069307
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)